2003
DOI: 10.1016/s1084-9521(03)00011-9
|View full text |Cite
|
Sign up to set email alerts
|

Transplantation of neural stem cells into the spinal cord after injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
98
0
1

Year Published

2005
2005
2024
2024

Publication Types

Select...
8
1
1

Relationship

2
8

Authors

Journals

citations
Cited by 143 publications
(102 citation statements)
references
References 50 publications
3
98
0
1
Order By: Relevance
“…Namely, the acute phase of SCI corresponds to the "inflammatory phase" due to the upregulation of inflammatory cytokines, excitatory neurotransmitters and free radicals, and is not suitable for transplantation, whereas in the chronic phase, about 2 weeks or more after injury, the injury enters the stage of glial scar formation, which prevents axonal regeneration. Therefore, the subacute phase of SCI is considered as the optimal time window for NS/PC transplantation in a rat SCI model [10,12,19] (Figure 1). However, we have to realize that the anatomy and functions of the spinal cord are considerably different between rodents and primates.…”
Section: Regenerative Medicine For Sci Using Fetal-derived Ns/pcsmentioning
confidence: 99%
“…Namely, the acute phase of SCI corresponds to the "inflammatory phase" due to the upregulation of inflammatory cytokines, excitatory neurotransmitters and free radicals, and is not suitable for transplantation, whereas in the chronic phase, about 2 weeks or more after injury, the injury enters the stage of glial scar formation, which prevents axonal regeneration. Therefore, the subacute phase of SCI is considered as the optimal time window for NS/PC transplantation in a rat SCI model [10,12,19] (Figure 1). However, we have to realize that the anatomy and functions of the spinal cord are considerably different between rodents and primates.…”
Section: Regenerative Medicine For Sci Using Fetal-derived Ns/pcsmentioning
confidence: 99%
“…Additionally, the central nervous system (CNS) has limited intrinsic regenerative capacity. Transplantation of neural stem or precursor cells has been used as a reliable therapeutic strategy in restoring tissue damage and regaining lost function in the CNS [1][2][3][4]. Direct cell transplantation, however, suffers several disadvantages such as limited survival upon implant ation and the formation of abnormal cell architecture in vivo [5].…”
Section: Introductionmentioning
confidence: 99%
“…These cells have the ability to self-renew and the multipotent potential to differentiate into neurons, astrocytes and oligodendrocytes. In the name of neuronal cell replacement, transplantation of NSCs has been challenged in a wide range of animal models of diseases and injuries such as Parkinson's disease, Huntington's disease, stroke and spinal cord injury, and functional recovery has often been reported [27,28,35,41,46,63]. As to muscle tissue, muscle stem cells and satellite cells isolated from adult and prenatal tissues [3,21,50,68] and myogenic stem cells contained in the bone marrow [25,64] are considered to be a source of stem cells, and there have been several attempts to ameliorate muscle degeneration by transplantation of these muscle stem cells [25].…”
Section: Introductionmentioning
confidence: 99%